Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina

Costs associated with complications are

Costs associated with complications are lower with capecitabine than with 5-fluorouracil in patients with colorectal cancer

✍ Edward Chu; Kathy L. Schulman; Susan Zelt; Xue Song 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Cardiotoxicity in cancer patients treate

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

✍ Polk, Anne; Vaage-Nilsen, Merete; Vistisen, Kirsten; Nielsen, Dorte L 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 553 KB

Doxorubicin versus methotrexate both com

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

✍ M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouri 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Doxorubicin versus methotrexate both com

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

✍ M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouri 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

To evaluate the substitution of methotrexate with doxorubicin (Dox) in CMF-(cyclophosphamide, methotrexate, 5-fluorouracil) containing regimen for advanced breast cancer, 415 postmenopausal patients below the age of 66 years, naïve to chemotherapy, were accrued from 1980 to 1984 and followed-up unti

Doxorubicin and cyclophosphamide adjuvan

Doxorubicin and cyclophosphamide adjuvant chemotherapy is no more effective than cyclophosphamide, methotrexate, and 5-fluorouracil for premenopausal axillary lymph node positive breast cancer: There is no clear evidence that HER-2 status affects the relative effects of doxorubicin and cyclophosphamide vs cyclophosphamide, methotrexate and 5-fluorouracil in women with operable breast cancer

✍ Dino Amadori 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 346 KB